News
Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...
TipRanks on MSN21h
Pacira collabs with J&J’s MedTech to expand market reach of ZILRETTA
Pacira BioSciences (PCRX) announced a strategic collaboration with Johnson & Johnson (JNJ) MedTech to significantly expand the market reach of ...
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...
Johnson & Johnson MedTech (NYSE:JNJ) today announced a strategic co-promotion agreement with Pacira BioSciences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback